Processa Pharmaceuticals, Inc. Accrued Rent, Current
Processa Pharmaceuticals, Inc. (PCSA) had Accrued Rent, Current of $9.96 thousand as of 2018-12-31, per its 10-K/A filed 2019-04-08.
Discontinued › Notes
us-gaap:AccruedRentCurrent · last filed 2019-04-08
- 2018-12-31: Accrued Rent, Current $9.96K.
- 2017-12-31: Accrued Rent, Current $3.32K.
| Period end | Accrued Rent, Current |
|---|---|
| 2018-12-31 | $9.96K 10-K/A · filed 2019-04-08 |
| 2017-12-31 | $3.32K 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |